Top News Stories
Health Care Reform
Pharma giants move to defend 340B rebate model
By Alan GoforthAbbVie, Bristol Myers Squibb, Boehringer Ingelheim and PhRMA want to defend the rebate plans that the Health Resources and Services Administration approved for their drugs.








